Form 4 · Filed Jun 1, 2026, 09:20 PM UTC
SNSE/Sensei Biotherapeutics, Inc.
Peyer James — 10pct_owner
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
2 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 1, 2026 | S | sell | 24,524 | $20 | $490,480 | 130,618 |
| Jun 1, 2026 | S | sell | 476 | $21 | $10,063 | 130,142 |
Source: SEC EDGAR raw filing ↗ · Accession 0000897069-26-001297